Menlo Park, United States
Synthego, founded in 2012, is positioned as a leader in the biotechnology industry, focusing on CRISPR solutions that expedite life science research and advancements in human health. Operating out of the United States, it serves industries spanning AI, Automation, Biotechnology, Life Sciences, and Machine Learning. Their recent strategic buyout investment on 01 July 2025, led by Perceptive Advisors, underscores investor confidence in their cutting-edge capabilities.
Synthego is committed to innovation, collaboration, and ethical practice. The company integrates diversity and inclusivity into its core values, further embodied through its Diversity Network Association (DNA), which promotes equity and inclusion as fundamental to its success. Synthego's ethos also stresses creativity, collaboration, kindness, empowerment, and integrity, facilitating a culture of respect and groundbreaking scientific progress.
